SUMMARY Regional cerebral blood flow (rCBF) was studied using SPECT (single photon emission computed tomography) with 133-Xenon in 13 patients with confirmed Sturge-Weber disease, aged 9 months to 18 years. CT scan, performed at the same time, showed evident cerebral angioma in 10 but not in three. A marked hypoperfused area was found in all patients, ranging from -32% to -72% and of the same location as the CT signs. The hypoperfusion seems to result from post ictal phenomenon as well as from chronic ischaemia. SPECT imaging is therefore a sensitive method for visualising intracranial angioma in Sturge-Weber disease and it provides an aid for diagnosis when a CT scan is not reliable.
Hypometabolism but also hypermetabolism have recently been reported using positron emission tomography (PET).9 We studied regional cerebral blood flow (rCBF) in children with confirmed SW disease to determine whether a characteristic rCBF pattern exists and to test the diagnostic value of this technique with that of CT.
Patients
We studied thirteen patients, eight boys and five girls, aged between 9 months and 18 years (mean 6 years). The examinations were performed with the informed consent of the children's parents.
All 13 were diagnosed as having SW disease. Diagnostic criteria are summarised in table 1. Facial angioma was found in all patients except one (number 5). In this case, the neurological and radiological characteristics were those of Sturge-Weber disease; arteriography was normal, excluding other types of vascular malformation. Two patients did not have seizures before SPECT imaging (numbers 8, 9); one of these showed neither neurological disorders nor mental retardation (number 8) but there was no doubt about cutaneous and cerebral angioma. All patients showed asymmetrical electroencephalographic features, including depressed background activity on the side of the angioma (fig lb) , interictal focal epileptiform activity (fig 4b) , or focal epileptic discharges (fig lc) . In ten patients, the CT revealed a typical pattern of intracranial angioma; for the three others, the CT disclosed only focal atrophy (number 9), only contrast enhancement (number 7) , or no abnormality (number 12).
Regional cerebral bloodflow by SPECT imaging in Sturge-Weber disease: an aidfor diagnosis 6 and 7 respectively); no neurological changes were observed during this time interval. The ROI employed on SPECT images were traced on the CT images after the size of the ROI was homothetically reproduced on the CT image. Three types of abnormalities were studied on the CT scan: calcifications, atrophy and contrast enhancement after injection.
Results
In six patients (numbers 1-4, 11, 13), the CT abnormalities were large since contrast enhancement and calcifications covered an entire hemisphere. In all six patients, an rCBF decrease was observed in a large cortical and subcortical area of the same hemisphere. In the cortex, the hypoperfused area was approximately of the same size as the CT abnormal area ( fig  I a) . In the subcortical regions, the size of the hypoperfused area was easily measured, but could not be compared with that of the CT abnormal area which was poorly defined. The intensity of the rCBF decrease was considerable, with maximal value ranging from 32% to 72% depending on the patients. In six patients (numbers 5-10), the CT abnormalities covered a small area. In all six, an rCBF decrease was found in an area corresponding to the CT scan abnormal area. In the cortical region, the size of the hypoperfused area was similar to that of the CT abnormal image in three patients ( fig 2) and slightly larger in the other three (numbers 7, 9, 10) (figs 3, 4). In these six patients, the rCBF decrease was also marked, with individual values ranging from 32% to 45%.
In the remaining patient (number 12), SPECT showed a localised rCBF decrease, with maximal decrease of 50%, although the CT was normal ( fig 5) .
These results show that in all the patients in this series, SPECT clearly defined a hypoperfused area, which was also seen in the patients with or without the typical appearance of angioma on CT.
Discussion
The diagnosis of Sturge-Weber disease is based on the association of clinical and radiological characteristics. Cutaneous angioma is usually present at birth. Epilepsy usually appears in the first years of life and hemiplegia follows the first prolonged seizures although some patients may remain seizure free. Cerebral angioma is constant but radiological characteristics may be delayed, or reduced to non-specific features, or may even be occasionally absent. SturgeWeber disease is easily diagnosed when all the features are present, but diagnosis is difficult when the neurological characteristics are absent, and especially when a CT provided no additional information. An additional diagnostic method would therefore be useful.
The method used to measure rCBF has been previously described.'0 It is easy to perform, does not require any blood samples, and only takes 5 minutes. The SPECT system used is especially adapted to the brain and is highly sensitive. The validity of this method has been studied for the cortex by comparing rCBF values in the same patients with those obtained by SPECT and PET using continuous inhalation of C'502. The rCBF values obtained by both methods were significantly correlated." Adapting the SPECT technique for children required two modifications: intravenous (IV) injection of the 133-Xenon instead of inhalation and the use of premedication.'2 Using the IV injection method, rCBF values increased by a mean of 10%, probably due to the shape of the Xenon input curve.'3 The premedication used (pentobarbital and droperidol) did not cause any significant change in rCBF in our research.
A study of patients with confirmed Sturge-Weber disease was necessary to test the ability of SPECT imaging to visualise the intracranial angioma. Our results show that all patients had a marked hypo- 
